<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>DIETHYLPROPION HYDROCHLORIDE
                                    Â - diethylpropion hydrochlorideÂ tabletÂ </strong><br>Unit Dose Services<br></p></div>
<h1>
<span class="Bold">Diethylpropion HCl USPÂ Â Â Â  CIV</span><span class="Bold"><br></span><span class="Bold">25 mg Tablets</span>
</h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="section-1"></a><p></p>
<h1></h1>
<p class="First"><span class="Bold">Rx Only</span></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="section-2"></a><p></p>
<h1><span class="Bold">DESCRIPTION</span></h1>
<p class="First">Diethylpropion hydrochloride is available for oral administration in immediate-release tablets containing 25 mg diethylpropion hydrochloride. The inactive ingredients in each immediate-release tablet are: crospovidone, lactose anhydrous, magnesium stearate, starch pregelatinized and tartaric acid. Diethylpropion hydrochloride is a sympathomimetic agent. The chemical name for diethylpropion hydrochloride is 1-phenyl-2-diethylamino-1-propanone hydrochloride.</p>
<p>Its chemical structure is:</p>
<div class="Figure"><img alt="36512f30-figure-01" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=31b58e5e-60af-4466-bd20-4b648e867e64&amp;name=36512f30-figure-01.jpg"></div>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="b13010ee-8468-4a48-b37b-b064faae5160"></a><a name="section-3"></a><p></p>
<h1><span class="Bold">CLINICAL PHARMACOLOGY</span></h1>
<p class="First">Diethylpropion hydrochloride is a sympathomimetic amine with some pharmacologic activity similar to that of the prototype drugs of this class used in <span class="product-label-link" type="condition" conceptid="433736" conceptname="Obesity">obesity</span>, the amphetamines. Actions include some central nervous system stimulation and elevation of blood pressure. Tolerance has been demonstrated with all drugs of this class in which these phenomena have been looked for.</p>
<p>Drugs of this class used in <span class="product-label-link" type="condition" conceptid="433736" conceptname="Obesity">obesity</span> are commonly known as "<span class="product-label-link" type="condition" conceptid="442165" conceptname="Loss of appetite">anorectics</span>" or "anorexigenics." It has not been established, however, that the action of such drugs in treating <span class="product-label-link" type="condition" conceptid="433736" conceptname="Obesity">obesity</span> is primarily one of <span class="product-label-link" type="condition" conceptid="442165" conceptname="Loss of appetite">appetite suppression</span>. For example, other central nervous system actions or metabolic effects may be involved. Adult obese subjects instructed in dietary management and treated with "<span class="product-label-link" type="condition" conceptid="442165" conceptname="Loss of appetite">anorectic</span>" drugs lose more weight on the average than those treated with placebo and diet, as determined in relatively short-term clinical trials. The magnitude of increased <span class="product-label-link" type="condition" conceptid="4134010" conceptname="Weight decreased">weight loss</span> of drug-treated patients over placebo-treated patients averages some fraction of a pound a week. However, individual <span class="product-label-link" type="condition" conceptid="4134010" conceptname="Weight decreased">weight loss</span> may vary substantially from patient to patient. The rate of <span class="product-label-link" type="condition" conceptid="4134010" conceptname="Weight decreased">weight loss</span> is greatest in the first weeks of therapy for both drug and placebo subjects and tends to decrease in succeeding weeks. The possible origins of the increased <span class="product-label-link" type="condition" conceptid="4134010" conceptname="Weight decreased">weight loss</span> due to the various drug effects are not established. The amount of <span class="product-label-link" type="condition" conceptid="4134010" conceptname="Weight decreased">weight loss</span> associated with the use of an "<span class="product-label-link" type="condition" conceptid="442165" conceptname="Loss of appetite">anorectic</span>" drug varies from trial to trial, and the increased <span class="product-label-link" type="condition" conceptid="4134010" conceptname="Weight decreased">weight loss</span> appears to be related in part to variables other than the drug prescribed, such as the physician/investigator relationship, the population treated, and the diet prescribed. Studies do not permit conclusions as to the relative importance of the drug and non-drug factors on <span class="product-label-link" type="condition" conceptid="4134010" conceptname="Weight decreased">weight loss</span>.</p>
<p>The natural history of <span class="product-label-link" type="condition" conceptid="433736" conceptname="Obesity">obesity</span> is measured in years, whereas most studies cited are restricted to a few weeks duration; thus, the total impact of drug-induced <span class="product-label-link" type="condition" conceptid="4134010" conceptname="Weight decreased">weight loss</span> over that of diet alone is unknown. Diethylpropion is rapidly absorbed from the GI tract after oral administration and is extensively metabolized through a complex pathway of biotransformation involving N-dealkylation and reduction. Many of these metabolites are biologically active and may participate in the therapeutic action of diethylpropion hydrochloride. Due to the varying lipid solubilities of these metabolites, their circulating levels are affected by urinary pH. Diethylpropion and/or its active metabolites are believed to cross the blood-brain barrier and the placenta.</p>
<p>Diethylpropion and its metabolites are excreted mainly by the kidney. It has been reported that between 75-106% of the dose is recovered in the urine within 48 hours after dosing. Using a phosphorescence assay that is specific for basic compounds containing a benzoyl group, the plasma half-life of the aminoketone metabolites is estimated to be between 4 to 6 hours.</p>
<p>The extended-release characteristics of the diethylpropion hydrochloride 75 mg formulation have been demonstrated by studies in humans in which plasma levels of diethylpropion-related materials were measured by phosphorescence analysis. Plasma levels obtained with the 75 mg diethylpropion hydrochloride formulation administered once daily indicated a more gradual release than an immediate-release formulation (three 25 mg tablets given in a single dose).</p>
<p>The diethylpropion hydrochloride 75 mg extended -release formulation has not been shown superior in effectiveness to the same dosage of the immediate-release formulation (one 25 mg tablet three times daily). After administration of a single dose of the diethylpropion hydrochloride 75 mg formulation (one 75 mg extended -release tablet) or diethylpropion hydrochloride solution (75 mg dose) in a crossover study using normal human subjects, the amount of parent compound and its active metabolites recovered in the urine within 48 hours for the two dosage forms were not statistically different.</p>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="section-4"></a><p></p>
<h1><span class="Bold">INDICATIONS &amp; USAGE</span></h1>
<p class="First">Diethylpropion hydrochloride is indicated in the management of exogenous <span class="product-label-link" type="condition" conceptid="433736" conceptname="Obesity">obesity</span> as a short-term adjunct (a few weeks) in a regimen of weight reduction based on caloric restriction in patients with an initial body <span class="product-label-link" type="condition" conceptid="4041088" conceptname="Mass">mass</span> index (BMI) of 30 kg/m or higher and who have not responded to appropriate weight reducing regimen (diet and/or exercise) alone. Below is a chart of BMI based on various heights and weights. BMI is calculated by taking the patientâ€™s weight, in kilograms (kg), divided by the patientâ€™s height, in meters (m), squared. Metric conversions are as follows: pounds divided by 2.2 = kg; inches x 0.0254 = meters.
                            <span class="Sup">2</span></p>
<table frame="void" width="629">
<caption><span>Body <span class="product-label-link" type="condition" conceptid="4041088" conceptname="Mass">Mass</span> Index (BMI), kg/m
                                <span class="Sup">2</span></span></caption>
<thead>
<tr class="First">
<td class="BotruleLruleRruleToprule" align="left" rowspan="2" valign="top">Weight (pounds)</td>
<td class="BotruleLruleRruleToprule" align="left" colspan="6" valign="top">Height (feet, inches)</td>
</tr>
<tr class="Last">
<td class="BotruleLruleRruleToprule" align="center" valign="top">5â€™0â€?</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">5â€™3â€?</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">5â€™6â€?</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">5â€™9â€?</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">6â€™0â€?</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">6â€™3â€?</td>
</tr>
</thead>
<tbody>
<tr class="First">
<td class="BotruleLruleRruleToprule" align="left" valign="top">140</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">27</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">25</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">23</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">21</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">19</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">18</td>
</tr>
<tr>
<td class="BotruleLruleRruleToprule" align="left" valign="top">150</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">29</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">27</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">24</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">22</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">20</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">19</td>
</tr>
<tr>
<td class="BotruleLruleRruleToprule" align="left" valign="top">160</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">31</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">28</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">26</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">24</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">22</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">20</td>
</tr>
<tr>
<td class="BotruleLruleRruleToprule" align="left" valign="top">170</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">33</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">30</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">28</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">25</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">23</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">21</td>
</tr>
<tr>
<td class="BotruleLruleRruleToprule" align="left" valign="top">180</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">35</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">32</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">29</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">27</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">25</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">23</td>
</tr>
<tr>
<td class="BotruleLruleRruleToprule" align="left" valign="top">190</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">37</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">34</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">31</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">28</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">26</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">24</td>
</tr>
<tr>
<td class="BotruleLruleRruleToprule" align="left" valign="top">200</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">39</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">36</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">32</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">30</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">27</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">25</td>
</tr>
<tr>
<td class="BotruleLruleRruleToprule" align="left" valign="top">210</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">41</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">37</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">34</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">31</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">29</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">26</td>
</tr>
<tr>
<td class="BotruleLruleRruleToprule" align="left" valign="top">220</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">43</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">39</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">36</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">33</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">30</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">28</td>
</tr>
<tr>
<td class="BotruleLruleRruleToprule" align="left" valign="top">230</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">45</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">41</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">37</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">34</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">31</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">29</td>
</tr>
<tr>
<td class="BotruleLruleRruleToprule" align="left" valign="top">240</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">47</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">43</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">39</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">36</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">33</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">30</td>
</tr>
<tr class="Last">
<td class="BotruleLruleRruleToprule" align="left" valign="top">250</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">49</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">44</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">40</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">37</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">34</td>
<td class="BotruleLruleRruleToprule" align="center" valign="top">31</td>
</tr>
</tbody>
</table>
<p>The usefulness of agents of this class (see ) should be measured against possible risk factors inherent in their use such as those described below. Diethylpropion hydrochloride is indicated for use as monotherapy only.
                            <span class="Italics"><a href="#b13010ee-8468-4a48-b37b-b064faae5160">CLINICAL PHARMACOLOGY</a></span></p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="b6214f66-215b-4377-891b-90400f86685c"></a><a name="section-5"></a><p></p>
<h1><span class="Bold">CONTRAINDICATIONS</span></h1>
<p class="First"><span class="product-label-link" type="condition" conceptid="4322024" conceptname="Pulmonary hypertension">Pulmonary hypertension</span>, advanced <span class="product-label-link" type="condition" conceptid="4103842" conceptname="Arteriosclerosis">arteriosclerosis</span>, <span class="product-label-link" type="condition" conceptid="4142479" conceptname="Hyperthyroidism">hyperthyroidism</span>, known <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> or idiosyncrasy to the sympathomimetic amines, <span class="product-label-link" type="condition" conceptid="437541" conceptname="Glaucoma">glaucoma</span>, severe <span class="product-label-link" type="condition" conceptid="316866" conceptname="Hypertensive disorder">hypertension</span>. (See .)
                            <span class="Italics"><a href="#b08264ec-9e94-4096-84b3-f4729d6188ac">PRECAUTIONS</a></span></p>
<p><span class="product-label-link" type="condition" conceptid="436087" conceptname="Excitement">Agitated</span> states.</p>
<p>Patients with a history of drug abuse.</p>
<p>Use in combination with other <span class="product-label-link" type="condition" conceptid="442165" conceptname="Loss of appetite">anorectic</span> agents is contraindicated.</p>
<p>During or within 14 days following the administration of monoamine oxidase inhibitors, hypertensive crises may result.</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="b40e23ae-df71-431f-8122-60ce273cb64c"></a><a name="section-6"></a><p></p>
<h1><span class="Bold">WARNINGS</span></h1>
<p class="First"><span class="Bold">Diethylpropion hydrochloride should not be used in combination with other <span class="product-label-link" type="condition" conceptid="442165" conceptname="Loss of appetite">anorectic</span> agents, including prescribed drugs, over-the-counter preparations, and herbal products.</span></p>
<p><span class="Bold">In a case-control epidemiological study, the use of <span class="product-label-link" type="condition" conceptid="442165" conceptname="Loss of appetite">anorectic</span> agents, including diethylpropion, was associated with an increased risk of developing <span class="product-label-link" type="condition" conceptid="4322024" conceptname="Pulmonary hypertension">pulmonary hypertension</span>, a rare, but often fatal disorder. The use of <span class="product-label-link" type="condition" conceptid="442165" conceptname="Loss of appetite">anorectic</span> agents for longer than 3 months was associated with a 23-fold increase in the risk of developing <span class="product-label-link" type="condition" conceptid="4322024" conceptname="Pulmonary hypertension">pulmonary hypertension</span>. Increased risk of <span class="product-label-link" type="condition" conceptid="4322024" conceptname="Pulmonary hypertension">pulmonary hypertension</span> with repeated courses of therapy cannot be excluded.</span></p>
<p>The onset or aggravation of <span class="product-label-link" type="condition" conceptid="4263848" conceptname="Dyspnea on exertion">exertional dyspnea</span>, or unexplained symptoms of <span class="product-label-link" type="condition" conceptid="321318" conceptname="Angina pectoris">angina pectoris</span>, <span class="product-label-link" type="condition" conceptid="135360" conceptname="Syncope">syncope</span>, or lower extremity <span class="product-label-link" type="condition" conceptid="433595" conceptname="Edema">edema</span> suggest the possibility of occurrence of <span class="product-label-link" type="condition" conceptid="4322024" conceptname="Pulmonary hypertension">pulmonary hypertension</span>. Under these circumstances, diethylpropion hydrochloride should be immediately discontinued, and the patient should be evaluated for the possible presence of <span class="product-label-link" type="condition" conceptid="4322024" conceptname="Pulmonary hypertension">pulmonary hypertension</span>.</p>
<p>The potential risk of possible serious adverse effects such as <span class="product-label-link" type="condition" conceptid="4281749" conceptname="Heart valve disorder">valvular heart disease</span> and <span class="product-label-link" type="condition" conceptid="4322024" conceptname="Pulmonary hypertension">pulmonary hypertension</span> should be assessed carefully against the potential benefit of <span class="product-label-link" type="condition" conceptid="4134010" conceptname="Weight decreased">weight loss</span>. Baseline cardiac evaluation should be considered to detect preexisting <span class="product-label-link" type="condition" conceptid="4281749" conceptname="Heart valve disorder">valvular heart diseases</span> or <span class="product-label-link" type="condition" conceptid="4322024" conceptname="Pulmonary hypertension">pulmonary hypertension</span> prior to initiation of diethylpropion hydrochloride treatment. Diethylpropion hydrochloride is not recommended in patients with known <span class="product-label-link" type="condition" conceptid="316822" conceptname="Heart murmur">heart murmur</span> or <span class="product-label-link" type="condition" conceptid="4281749" conceptname="Heart valve disorder">valvular heart disease</span>. Echocardiogram during and after treatment could be useful for detecting any valvular disorders which may occur.
                            <span class="Bold"><span class="product-label-link" type="condition" conceptid="4281749" conceptname="Heart valve disorder">Valvular heart disease</span> associated with the use of some <span class="product-label-link" type="condition" conceptid="442165" conceptname="Loss of appetite">anorectic</span> agents such as fenfluramine and dexfenfluramine has been reported. Possible contributing factors include use for extended periods of time, higher than recommended dose, and/or use in combination with other <span class="product-label-link" type="condition" conceptid="442165" conceptname="Loss of appetite">anorectic</span> drugs. Valvulopathy has been very rarely reported with diethylpropion hydrochloride monotherapy, but the causal relationship remains uncertain.</span></p>
<p>To limit unwarranted exposure and risks, treatment with diethylpropion hydrochloride should be continued only if the patient has satisfactory <span class="product-label-link" type="condition" conceptid="4134010" conceptname="Weight decreased">weight loss</span> within the first 4 weeks of treatment (e.g., <span class="product-label-link" type="condition" conceptid="4134010" conceptname="Weight decreased">weight loss</span> of at least 4 pounds, or as determined by the physician and patient).</p>
<p>Diethylpropion hydrochloride is not recommended for patients who used any <span class="product-label-link" type="condition" conceptid="442165" conceptname="Loss of appetite">anorectic</span> agents within the prior year.</p>
<p>If tolerance develops, the recommended dose should not be exceeded in an attempt to increase the effect; rather, the drug should be discontinued. Diethylpropion hydrochloride may impair the ability of the patient to engage in potentially hazardous activities such as operating machinery or driving a motor vehicle; the patient should therefore be cautioned accordingly.</p>
<p>Prolonged use of diethylpropion hydrochloride may induce <span class="product-label-link" type="condition" conceptid="4113279" conceptname="Dependence">dependence</span> with withdrawal syndrome on cessation of therapy. <span class="product-label-link" type="condition" conceptid="433031" conceptname="Hallucinations">Hallucinations</span> have occurred rarely following high doses of the drug. Several cases of toxic <span class="product-label-link" type="condition" conceptid="436073" conceptname="Psychotic disorder">psychosis</span> have been reported following the excessive use of the drug and some have been reported in which the recommended dose appears not to have been exceeded. <span class="product-label-link" type="condition" conceptid="436073" conceptname="Psychotic disorder">Psychosis</span> abated after the drug was discontinued.</p>
<p>When central nervous system active agents are used, consideration must always be given to the possibility of adverse interactions with alcohol.</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="b08264ec-9e94-4096-84b3-f4729d6188ac"></a><a name="section-7"></a><p></p>
<h1><span class="Bold">PRECAUTIONS</span></h1>
<div class="Section" data-sectionCode="34072-9">
<a name="section-7.1"></a><p></p>
<h2><span class="Bold Underline">General</span></h2>
<p class="First">Caution is to be exercised in prescribing diethylpropion hydrochloride for patients with <span class="product-label-link" type="condition" conceptid="316866" conceptname="Hypertensive disorder">hypertension</span> or with symptomatic cardiovascular disease, including <span class="product-label-link" type="condition" conceptid="44784217" conceptname="Cardiac arrhythmia">arrhythmias</span>. Diethylpropion hydrochloride should not be administered to patients with severe <span class="product-label-link" type="condition" conceptid="316866" conceptname="Hypertensive disorder">hypertension</span>.</p>
<p>Reports suggest that diethylpropion hydrochloride may increase <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">convulsions</span> in some epileptics. Therefore, epileptics receiving diethylpropion hydrochloride should be carefully monitored. Titration of dose or discontinuance of diethylpropion hydrochloride may be necessary.</p>
<p>The least amount feasible should be prescribed or dispensed at one time in order to minimize the possibility of overdosage.</p>
</div>
<div class="Section" data-sectionCode="34076-0">
<a name="section-7.2"></a><p></p>
<h2><span class="Bold Underline">Information for Patient</span></h2>
<p class="First">The patient should be cautioned about concomitant use of alcohol or other CNS-active drugs and diethylpropion hydrochloride. (See .) The patient should be advised to observe caution when driving or engaging in any potentially hazardous activity.
                                    <span class="Italics"><a href="#b40e23ae-df71-431f-8122-60ce273cb64c">WARNINGS</a></span></p>
</div>
<div class="Section" data-sectionCode="34075-2">
<a name="section-7.3"></a><p></p>
<h2><span class="Bold Underline">Laboratory Tests</span></h2>
<p class="First">None.</p>
</div>
<div class="Section" data-sectionCode="34073-7">
<a name="section-7.4"></a><p></p>
<h2><span class="Bold Underline">Drug Interactions</span></h2>
<p class="First">Because diethylpropion hydrochloride is a monoamine, <span class="product-label-link" type="condition" conceptid="316866" conceptname="Hypertensive disorder">hypertension</span> may result when this agent is used with monoamine oxidase (MAO) inhibitors (see ).
                                    <span class="Italics"><a href="#b6214f66-215b-4377-891b-90400f86685c">CONTRAINDICATIONS</a></span></p>
<p>Efficacy of diethylpropion with other <span class="product-label-link" type="condition" conceptid="442165" conceptname="Loss of appetite">anorectic</span> agents has not been studied and the combined use may have the potential for serious cardiac problems; therefore, the concomitant use with other <span class="product-label-link" type="condition" conceptid="442165" conceptname="Loss of appetite">anorectic</span> agents is contraindicated.</p>
<p>Antidiabetic drug requirements (i.e., insulin) may be altered. Concurrent use with general anesthetics may result in <span class="product-label-link" type="condition" conceptid="44784217" conceptname="Cardiac arrhythmia">arrhythmias</span>. The pressor effects of diethylpropion and those of other drugs may be additive when the drugs are used concomitantly; conversely, diethylpropion may interfere with antihypertensive drugs (i.e., guanethidine, Î±-methyldopa). Concurrent use of phenothiazines may antagonize the <span class="product-label-link" type="condition" conceptid="442165" conceptname="Loss of appetite">anorectic</span> effect of diethylpropion.</p>
</div>
<div class="Section" data-sectionCode="34083-6">
<a name="section-7.5"></a><p></p>
<h2><span class="Bold Underline">Carcinogenesis, Mutagenesis, and Impairment of Fertility</span></h2>
<p class="First"><a name="bfb1fa70-514e-436b-a186-36e4755afa46"></a>No long-term animal studies have been done to evaluate diethylpropion hydrochloride for carcinogenicity. Mutagenicity studies have not been conducted. Animal reproduction studies have revealed no evidence of impairment of fertility (see ).
                                    <span class="Italics"><a href="#bfb1fa70-514e-436b-a186-36e4755afa46">Pregnancy</a></span></p>
</div>
<div class="Section" data-sectionCode="42228-7">
<a name="section-7.6"></a><p></p>
<h2><span class="Bold Underline">Pregnancy</span></h2>
<p class="First">Reproduction studies have been performed in rats at doses up to 1.6 times the human dose (based on mg/m ) and have revealed no evidence of impaired fertility or harm to the fetus due to diethylpropion hydrochloride. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed.
                                    <span class="Bold">Teratogenic Effects: Pregnancy Category B.</span><span class="Sup">2</span></p>
<p>Spontaneous reports of congenital malformations have been recorded in humans, but no causal relationship to diethylpropion has been established.</p>
<p>Abuse with diethylpropion hydrochloride during pregnancy may result in withdrawal symptoms in the human neonate.
                                    <span class="Bold">Nonteratogenic Effects.</span></p>
</div>
<div class="Section" data-sectionCode="34080-2">
<a name="section-7.7"></a><p></p>
<h2><span class="Bold Underline">Nursing Mothers</span></h2>
<p class="First">Since diethylpropion hydrochloride and/or its metabolites have been shown to be excreted in human milk, caution should be exercised when diethylpropion hydrochloride is administered to a nursing woman.</p>
</div>
<div class="Section" data-sectionCode="34082-8">
<a name="b87b4385-98b7-43e9-a270-4c8d45e6e675"></a><a name="section-7.8"></a><p></p>
<h2><span class="Bold Underline">Geriatric Use</span></h2>
<p class="First">Clinical studies of diethylpropion hydrochloride did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. Other reported clinical experience has not identified differences in responses between the elderly and younger patients. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.</p>
<p>This drug is known to be substantially excreted by the kidney, and the risk of toxic reactions to this drug may be greater in patients with <span class="product-label-link" type="condition" conceptid="4030518" conceptname="Renal impairment">impaired renal function</span>. Because elderly patients are more likely to have decreased renal function, care should be taken in dose selection, and it may be useful to monitor renal function.</p>
</div>
<div class="Section" data-sectionCode="34081-0">
<a name="section-7.9"></a><p></p>
<h2><span class="Bold Underline">Pediatric Use</span></h2>
<p class="First">Since safety and effectiveness in pediatric patients below the age of 16 have not been established, diethylpropion hydrochloride is not recommended for use in pediatric patients 16 years of age and under.</p>
</div>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="section-8"></a><p></p>
<h1><span class="Bold">ADVERSE REACTIONS</span></h1>
<p class="First"><span class="product-label-link" type="condition" conceptid="77670" conceptname="Chest pain">Precordial pain</span>, <span class="product-label-link" type="condition" conceptid="44784217" conceptname="Cardiac arrhythmia">arrhythmia</span> (including ventricular), ECG changes, <span class="product-label-link" type="condition" conceptid="315643" conceptname="Tachyarrhythmia">tachycardia</span>, elevation of blood pressure, <span class="product-label-link" type="condition" conceptid="315078" conceptname="Palpitations">palpitation</span> and rare reports of <span class="product-label-link" type="condition" conceptid="4322024" conceptname="Pulmonary hypertension">pulmonary hypertension</span>. <span class="product-label-link" type="condition" conceptid="4281749" conceptname="Heart valve disorder">Valvular heart disease</span> associated with the use of some <span class="product-label-link" type="condition" conceptid="442165" conceptname="Loss of appetite">anorectic</span> agents such as fenfluramine and dexfenfluramine, both independently and especially when used in combination, have been reported. Valvulopathy has been very rarely reported with diethylpropion hydrochloride monotherapy, but the causal relationship remains uncertain.
                            <span class="Bold">Cardiovascular:</span></p>
<p>In a few epileptics an increase in convulsive episodes has been reported; rarely <span class="product-label-link" type="condition" conceptid="436073" conceptname="Psychotic disorder">psychotic episodes</span> at recommended doses; <span class="product-label-link" type="condition" conceptid="4047115" conceptname="Oral dyskinesia">dyskinesia</span>, <span class="product-label-link" type="condition" conceptid="4079185" conceptname="Hazy vision">blurred vision</span>, overstimulation, <span class="product-label-link" type="condition" conceptid="436817" conceptname="Feeling nervous">nervousness</span>, <span class="product-label-link" type="condition" conceptid="4012381" conceptname="Restlessness">restlessness</span>, <span class="product-label-link" type="condition" conceptid="4223938" conceptname="Dizziness">dizziness</span>, <span class="product-label-link" type="condition" conceptid="436817" conceptname="Feeling nervous">jitteriness</span>, <span class="product-label-link" type="condition" conceptid="436962" conceptname="Insomnia">insomnia</span>, <span class="product-label-link" type="condition" conceptid="441542" conceptname="Anxiety">anxiety</span>, <span class="product-label-link" type="condition" conceptid="4142453" conceptname="Feeling high">euphoria</span>, <span class="product-label-link" type="condition" conceptid="438727" conceptname="Atypical depressive disorder">depression</span>, <span class="product-label-link" type="condition" conceptid="4148767" conceptname="Dysphoric mood">dysphoria</span>, <span class="product-label-link" type="condition" conceptid="443782" conceptname="Tremor">tremor</span>, <span class="product-label-link" type="condition" conceptid="4290615" conceptname="Dilated pupil">mydriasis</span>, <span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">drowsiness</span>, <span class="product-label-link" type="condition" conceptid="4272240" conceptname="Malaise">malaise</span>, <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headache</span>, and <span class="product-label-link" type="condition" conceptid="381316" conceptname="Cerebrovascular accident">cerebrovascular accident</span>
                            <span class="Bold">Central Nervous System:</span></p>
<p><span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">Vomiting</span>, <span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">diarrhea</span>, <span class="product-label-link" type="condition" conceptid="4183041" conceptname="Abdominal discomfort">abdominal discomfort</span>, dryness of the mouth, unpleasant taste, <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>, <span class="product-label-link" type="condition" conceptid="75860" conceptname="Constipation">constipation</span>, other <span class="product-label-link" type="condition" conceptid="4302537" conceptname="Digestive system finding">gastrointestinal disturbances</span>
                            <span class="Bold">Gastrointestinal:</span></p>
<p><span class="product-label-link" type="condition" conceptid="139900" conceptname="Urticaria">Urticaria</span>, <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">rash</span>, <span class="product-label-link" type="condition" conceptid="4118793" conceptname="Ecchymosis">ecchymosis</span>, <span class="product-label-link" type="condition" conceptid="137193" conceptname="Erythema">erythema</span>
                            <span class="Bold">Allergic:</span></p>
<p><span class="product-label-link" type="condition" conceptid="4216771" conceptname="Impotence">Impotence</span>, changes in libido, <span class="product-label-link" type="condition" conceptid="4168447" conceptname="Gynecomastia">gynecomastia</span>, menstrual upset
                            <span class="Bold">Endocrine:</span></p>
<p><span class="product-label-link" type="condition" conceptid="4145241" conceptname="Bone marrow depression">Bone marrow depression</span>, <span class="product-label-link" type="condition" conceptid="440689" conceptname="Agranulocytosis">agranulocytosis</span>, <span class="product-label-link" type="condition" conceptid="435224" conceptname="Leukopenia">leukopenia</span>
                            <span class="Bold">Hematopoietic System:</span></p>
<p>A variety of miscellaneous adverse reactions has been reported by physicians. These include complaints such as <span class="product-label-link" type="condition" conceptid="197684" conceptname="Dysuria">dysuria</span>, <span class="product-label-link" type="condition" conceptid="312437" conceptname="Dyspnea">dyspnea</span>, <span class="product-label-link" type="condition" conceptid="133280" conceptname="Alopecia">hair loss</span>, <span class="product-label-link" type="condition" conceptid="442752" conceptname="Muscle pain">muscle pain</span>, increased <span class="product-label-link" type="condition" conceptid="138565" conceptname="Hyperhidrosis">sweating</span>, and <span class="product-label-link" type="condition" conceptid="79936" conceptname="Polyuria">polyuria</span>.
                            <span class="Bold">Miscellaneous:</span></p>
</div>
<div class="Section" data-sectionCode="42227-9">
<a name="section-9"></a><p></p>
<h1><span class="Bold">DRUG ABUSE AND <span class="product-label-link" type="condition" conceptid="4113279" conceptname="Dependence">DEPENDENCE</span></span></h1>
<p class="First">Diethylpropion hydrochloride is a schedule IV controlled substance. Diethylpropion hydrochloride has some chemical and pharmacologic similarities to the amphetamines and other related stimulant drugs that have been extensively abused. There have been reports of subjects becoming psychologically dependent on diethylpropion. The possibility of abuse should be kept in mind when evaluating the desirability of including a drug as part of a weight reduction program. Abuse of amphetamines and related drugs may be associated with varying degrees of psychologic <span class="product-label-link" type="condition" conceptid="4113279" conceptname="Dependence">dependence</span> and social dysfunction which, in the case of certain drugs, may be severe. There are reports of patients who have increased the dosage to many times that recommended. Abrupt cessation following prolonged high dosage administration results in extreme <span class="product-label-link" type="condition" conceptid="4223659" conceptname="Fatigue">fatigue</span> and mental <span class="product-label-link" type="condition" conceptid="438727" conceptname="Atypical depressive disorder">depression</span>; changes are also noted on the sleep EEG. Manifestations of chronic <span class="product-label-link" type="condition" conceptid="442562" conceptname="Poisoning">intoxication</span> with <span class="product-label-link" type="condition" conceptid="442165" conceptname="Loss of appetite">anorectic</span> drugs include severe dermatoses, marked <span class="product-label-link" type="condition" conceptid="436962" conceptname="Insomnia">insomnia</span>, <span class="product-label-link" type="condition" conceptid="4184149" conceptname="Feeling irritable">irritability</span>, <span class="product-label-link" type="condition" conceptid="4137162" conceptname="Overactive">hyperactivity</span>, and <span class="product-label-link" type="condition" conceptid="444092" conceptname="Personality change">personality changes</span>. The most severe manifestation of chronic <span class="product-label-link" type="condition" conceptid="442562" conceptname="Poisoning">intoxication</span> is <span class="product-label-link" type="condition" conceptid="436073" conceptname="Psychotic disorder">psychosis</span>, often clinically indistinguishable from <span class="product-label-link" type="condition" conceptid="435783" conceptname="Schizophrenia">schizophrenia</span>.</p>
</div>
<div class="Section" data-sectionCode="34088-5">
<a name="section-10"></a><p></p>
<h1><span class="Bold">OVERDOSAGE</span></h1>
<p class="First">Manifestations of acute overdosage include <span class="product-label-link" type="condition" conceptid="4012381" conceptname="Restlessness">restlessness</span>, <span class="product-label-link" type="condition" conceptid="443782" conceptname="Tremor">tremor</span>, <span class="product-label-link" type="condition" conceptid="4313132" conceptname="Hyperreflexia">hyperreflexia</span>, rapid respiration, <span class="product-label-link" type="condition" conceptid="381273" conceptname="Confusional state">confusion</span>, assaultiveness, <span class="product-label-link" type="condition" conceptid="433031" conceptname="Hallucinations">hallucinations</span>, panic states, and <span class="product-label-link" type="condition" conceptid="4290615" conceptname="Dilated pupil">mydriasis</span>.</p>
<p><span class="product-label-link" type="condition" conceptid="4223659" conceptname="Fatigue">Fatigue</span> and <span class="product-label-link" type="condition" conceptid="438727" conceptname="Atypical depressive disorder">depression</span> usually follow the central stimulation.</p>
<p>Cardiovascular effects include <span class="product-label-link" type="condition" conceptid="315643" conceptname="Tachyarrhythmia">tachycardia</span>, <span class="product-label-link" type="condition" conceptid="44784217" conceptname="Cardiac arrhythmia">arrhythmias</span>, <span class="product-label-link" type="condition" conceptid="316866" conceptname="Hypertensive disorder">hypertension</span> or <span class="product-label-link" type="condition" conceptid="316447" conceptname="Chronic hypotension">hypotension</span> and <span class="product-label-link" type="condition" conceptid="201965" conceptname="Shock">circulatory collapse</span>. <span class="product-label-link" type="condition" conceptid="4302537" conceptname="Digestive system finding">Gastrointestinal symptoms</span> include <span class="product-label-link" type="condition" conceptid="31967" conceptname="Nausea">nausea</span>, <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">vomiting</span>, <span class="product-label-link" type="condition" conceptid="80141" conceptname="Functional diarrhea">diarrhea</span>, and <span class="product-label-link" type="condition" conceptid="200219" conceptname="Abdominal pain">abdominal cramps</span>. <span class="product-label-link" type="condition" conceptid="4208104" conceptname="Drug overdose">Overdose</span> of pharmacologically similar compounds has resulted in <span class="product-label-link" type="condition" conceptid="377091" conceptname="Seizure">convulsions</span>, <span class="product-label-link" type="condition" conceptid="380834" conceptname="Coma">coma</span> and <span class="product-label-link" type="condition" conceptid="4306655" conceptname="Death">death</span>.</p>
<p>The reported oral LD for mice is 600 mg/kg, for rats is 250 mg/kg and for dogs is 225 mg/kg.
                            <span class="Sub">50</span></p>
<p>Management of acute diethylpropion hydrochloride <span class="product-label-link" type="condition" conceptid="442562" conceptname="Poisoning">intoxication</span> is largely symptomatic and includes lavage and sedation with a barbiturate. Experience with hemodialysis or peritoneal dialysis is inadequate to permit recommendation in this regard. Intravenous phentolamine (Regitine ) has been suggested on pharmacologic grounds for possible acute, severe <span class="product-label-link" type="condition" conceptid="316866" conceptname="Hypertensive disorder">hypertension</span>, if this complicates diethylpropion hydrochloride overdosage.
                            <span class="Sup">Â®</span></p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="section-11"></a><p></p>
<h1><span class="Bold">DOSAGE AND ADMINISTRATION</span></h1>
<p class="First">Diethylpropion hydrochloride immediate-release:</p>
<p>One immediate-release 25 mg tablet three times daily, one hour before meals, and in midevening if desired to overcome night <span class="product-label-link" type="condition" conceptid="4205415" conceptname="Hungry">hunger</span>.</p>
<div class="Section">
<a name="section-11.1"></a><p></p>
<h2><span class="Bold">Geriatric Use:</span></h2>
<p class="First">This drug is known to be substantially excreted by the kidney, and the risk of toxic reactions to this drug may be greater in patients with <span class="product-label-link" type="condition" conceptid="4030518" conceptname="Renal impairment">impaired renal function</span>. Because elderly patients are more likely to have decreased renal function, care should be taken in dose selection, and it may be useful to monitor renal function. (See )
                                    <span class="Italics"><a href="#b87b4385-98b7-43e9-a270-4c8d45e6e675">PRECAUTIONS, Geriatric Use</a></span><span class="Italics">.</span></p>
</div>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="section-12"></a><p></p>
<h1>DIETHYLPROPION HCL</h1>
<div class="Figure"><img alt="Label Image" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=31b58e5e-60af-4466-bd20-4b648e867e64&amp;name=rspl50436-4164.jpg"></div>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>DIETHYLPROPION HYDROCHLORIDE
                                    Â 		
					</strong><br><span class="contentTableReg">diethylpropion hydrochloride tablet</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:50436-4164(NDC:10702-044)</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">ORAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">CIVÂ Â Â Â 
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>DIETHYLPROPION HYDROCHLORIDE</strong> (DIETHYLPROPION) </td>
<td class="formItem">DIETHYLPROPION HYDROCHLORIDE</td>
<td class="formItem">25Â mg</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>CROSPOVIDONE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>LACTOSE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>MAGNESIUM STEARATE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>STARCH, CORN</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>TARTARIC ACID</strong></td>
<td class="formItem">Â </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Characteristics</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Color</td>
<td class="formItem">WHITE</td>
<td class="formLabel">Score</td>
<td class="formItem">no score</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Shape</td>
<td class="formItem">ROUND</td>
<td class="formLabel">Size</td>
<td class="formItem">10mm</td>
</tr>
<tr class="formTableRowAlt">
<td class="formLabel">Flavor</td>
<td class="formItem"></td>
<td class="formLabel">Imprint Code</td>
<td class="formItem">K;44</td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Contains</td>
<td class="formItem">Â Â Â Â </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:50436-4164-1</td>
<td class="formItem">21  in 1 BOTTLE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">2</th>
<td class="formItem">NDC:50436-4164-5</td>
<td class="formItem">100  in 1 BOTTLE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">ANDA</td>
<td class="formItem">ANDA201212</td>
<td class="formItem">12/27/2010</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler -Â </span>Unit Dose Services
							(831995316)
						</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Registrant -Â </span>Unit Dose Services (831995316)</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Unit Dose Services</td>
<td class="formItem"></td>
<td class="formItem">831995316</td>
<td class="formItem">REPACK(50436-4164)</td>
</tr>
</table>
</div>
<p><div class="EffectiveDate">Revised: 1/2011<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>70fac393-0c33-43da-a152-61dfd38ae346</div>
<div>Set id: 31b58e5e-60af-4466-bd20-4b648e867e64</div>
<div>Version: 3</div>
<div>Effective Time: 20110126</div>
</div>
</div>Â <div class="DistributorName">Unit Dose Services</div></p>
</body></html>
